Trial Profile
Study of non‑vitamin K antagonist anticoagulants strongly increased the rate of anticoagulation in hospitalized geriatric patients with atrial fibrillation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Aug 2018
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary) ; Apixaban; Dabigatran etexilate; Heparin; Phenprocoumon
- Indications Thromboembolism
- Focus Therapeutic Use
- 07 Aug 2018 New trial record
- 01 Aug 2018 Results (n=378) published in the Drugs and Aging